Role of VAPB-MSP, a Novel EphA2 RTK Antagonist in Breast Cancer

doi 10.21236/ada605663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy